Major Leadership Changes at the US Food and Drug Administration
Major Leadership Changes at the US Food and Drug Administration
Between early 2025 and April 2026, the U.S.
Food and Drug Administration (FDA) experienced significant organizational shifts.
Under the "Make America Healthy Again" agenda, Commissioner Dr.
Martin Makary was appointed in April 2025.
The FDA's focus has shifted toward deregulation, including removing certain animal testing requirements and simplifying approval processes.
New initiatives like the "PreCheck" program aim to reshore drug manufacturing.
Despite these changes, the agency faces a challenging climate of instability and unpredictability, impacting pharmaceutical and food industries.
